PlainRecalls
FDA Drug Moderate Class II Terminated

Trimix QM10 Papaverine 30 mg/Phentolamine 4 mg/Atropine 1 mg/PGE 150 mcg/mL Injectable, Pharm D Solutions, Houston, Texas --- NDC 69699-1352-05

Reported: November 7, 2018 Initiated: September 10, 2018 #D-0194-2019

Product Description

Trimix QM10 Papaverine 30 mg/Phentolamine 4 mg/Atropine 1 mg/PGE 150 mcg/mL Injectable, Pharm D Solutions, Houston, Texas --- NDC 69699-1352-05

Reason for Recall

Lack of Assurance of Sterility

Details

Recalling Firm
Pharm D Solutions, LLC
Units Affected
9 vials
Distribution
Nationwide
Location
Houston, TX

Frequently Asked Questions

What product was recalled?
Trimix QM10 Papaverine 30 mg/Phentolamine 4 mg/Atropine 1 mg/PGE 150 mcg/mL Injectable, Pharm D Solutions, Houston, Texas --- NDC 69699-1352-05. Recalled by Pharm D Solutions, LLC. Units affected: 9 vials.
Why was this product recalled?
Lack of Assurance of Sterility
Which agency issued this recall?
This recall was issued by the FDA Drug on November 7, 2018. Severity: Moderate. Recall number: D-0194-2019.